1.
Kasuma D, Soeroso NN, Tarigan SP, Syahruddin E. Survival Rate in Lung Adenocarcinoma with Mutation of the EGFR Gene with Tyrosine Kinase Inhibitor Treatment. Open Access Maced J Med Sci [Internet]. 2022 Apr. 10 [cited 2024 May 3];10(T7):199-204. Available from: https://oamjms.eu/index.php/mjms/article/view/9459